{
    "type": "ETF",
    "ucits": true,
    "fund_name": "Xtrackers Harvest CSI300 UCITS ETF",
    "replication_method": "physical",
    "leverage": false,
    "derivatives": false,
    "swaps": false,
    "inverse": false,
    "complex_factors": [],
    "classification": "non-complex",
    "supporting_data": "The Xtrackers Harvest CSI300 UCITS ETF aims to replicate the CSI300 Index by physically buying the underlying securities, either directly or through the Investment Manager's RQFII licence or the Shanghai-Hong Kong and Shenzhen-Hong Kong Stock Connect programs. The KIID and PRIIPs KID documents confirm the fund uses physical replication or representative sampling only when direct acquisition is restricted, with no mention of synthetic replication, swap agreements, or total return swaps. The factsheet explicitly states 'Direct Replication (physically)' as the portfolio methodology. There is no leverage or inverse exposure indicated in any document. The fund may use derivatives only for risk management purposes, which under MiFID II does not classify as inherent derivative use, so derivatives are marked false. The risk profile is medium-high (risk level 5 out of 7), reflecting market and country risks related to emerging markets and China-specific factors, but not complexity from product structure. No capital protection, contingent bonds, or structured features are present. Costs are straightforward with a single ongoing charge of 0.65% and no performance fees or swap fees. No complex indices or structured products are held. The fund is UCITS compliant and regulated by Luxembourg authorities. Therefore, the fund does not meet MiFID II criteria for a complex financial instrument."
}